T. Rowe Price Investment Management’s Guardian Pharmacy Services GRDN Stock Holding History

T. Rowe Price Investment Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.7M	Buy	+1,028,389	New	+$33.6M	0.03%	391

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management's GRDN Position: Q1 2026 in Review

T. Rowe Price Investment Management opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 1,028,389 shares worth $38.7M. The stake represents 0.03% of the portfolio and ranks #391 among its holdings.

171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

T. Rowe Price Investment Management held 1,028,389 shares of Guardian Pharmacy Services worth $38.7M as of Q1 2026.
Guardian Pharmacy Services was a new T. Rowe Price Investment Management position in Q1 2026.
Guardian Pharmacy Services made up 0.03% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #391 holding.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.